Vimarsana
Biggest News Aggregation in the World

Page 5 - Cameron Durrant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cameron Durrant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cameron Durrant Today - Breaking & Trending Today

Humanigen Announces Participation and Presentation at Multiple Conferences in May - Vimarsana News

Humanigen Announces Participation and Presentation at Multiple Conferences in May

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ announced today that management will present and participate at multiple investors conferences in May 2022. Details of the conferences are as follows:

Did Black Patients with COVID-19 See Greater Benefits with Novel Mab Therapy? - Vimarsana News

Did Black Patients with COVID-19 See Greater Benefits with Novel Mab Therapy?

LIVE-AIR data analysis shows significant improvements in survival without ventilation

California State Teachers Retirement System Lowers Holdings in Humanigen, Inc. (NASDAQ:HGEN) - Vimarsana News

California State Teachers Retirement System Lowers Holdings in Humanigen, Inc. (NASDAQ:HGEN)

California State Teachers Retirement System trimmed its holdings in Humanigen, Inc. (NASDAQ:HGEN – Get Rating) by 18.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 50,675 shares of the company’s stock after selling 11,177 shares during the quarter. California State Teachers Retirement […]

Humanigen Reports Year-End 2021 Financial Results - Vimarsana News

Humanigen Reports Year-End 2021 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Humanigen to Present and Participate at Multiple Investor Events in March - Vimarsana News

Humanigen to Present and Participate at Multiple Investor Events in March

Humanigen, Inc. , a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced today that management will... | February 25, 2022